These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18701260)

  • 1. Analysis of plasma and peritoneal fluid concentrations of daptomycin in a patient with Enterococcus faecium peritonitis.
    Burklein D; Heyn J; Kirchhoff C; Ozimek A; Traunmuller F; Joukhadar C; Rothenburger M; Mutschler W; Heindl B
    Int J Antimicrob Agents; 2008 Oct; 32(4):369-71. PubMed ID: 18701260
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful use of intraperitoneal daptomycin in the treatment of vancomycin-resistant enterococcus peritonitis.
    Huen SC; Hall I; Topal J; Mahnensmith RL; Brewster UC; Abu-Alfa AK
    Am J Kidney Dis; 2009 Sep; 54(3):538-41. PubMed ID: 19237231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy.
    Lewis JS; Owens A; Cadena J; Sabol K; Patterson JE; Jorgensen JH
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1664-5. PubMed ID: 15793168
    [No Abstract]   [Full Text] [Related]  

  • 4. Daptomycin for the treatment of vancomycin-resistant enterococcal infections.
    Grim SA; Hong I; Freeman J; Edwards C; Clark NM
    J Antimicrob Chemother; 2009 Feb; 63(2):414-6. PubMed ID: 19015143
    [No Abstract]   [Full Text] [Related]  

  • 5. Daptomycin for the treatment of vancomycin resistant Enterococcus faecium bacteremia.
    Kvirikadze N; Suseno M; Vescio T; Kaminer L; Singh K
    Scand J Infect Dis; 2006; 38(4):290-2. PubMed ID: 16709529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE).
    Mohr JF; Friedrich LV; Yankelev S; Lamp KC
    Int J Antimicrob Agents; 2009 Jun; 33(6):543-8. PubMed ID: 19201165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daptomycin-resistant Enteroccoccus faecium in a patient with no prior exposure to daptomycin.
    Fraher MH; Corcoran GD; Creagh S; Feeney E
    J Hosp Infect; 2007 Apr; 65(4):376-8. PubMed ID: 17316896
    [No Abstract]   [Full Text] [Related]  

  • 8. Rhabdomyolysis during therapy with daptomycin.
    Papadopoulos S; Ball AM; Liewer SE; Martin CA; Winstead PS; Murphy BS
    Clin Infect Dis; 2006 Jun; 42(12):e108-10. PubMed ID: 16705566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of vancomycin-resistant Enterococcus faecium pyelonephritis with daptomycin during pregnancy.
    Shea K; Hilburger E; Baroco A; Oldfield E
    Ann Pharmacother; 2008 May; 42(5):722-5. PubMed ID: 18349306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of daptomycin β-Lactam combination therapy to prevent resistance emergence in Enterococcus faecium.
    Menon V; Davis R; Shackel N; Espedido BA; Beukers AG; Jensen SO; van Hal SJ
    Diagn Microbiol Infect Dis; 2018 Feb; 90(2):120-122. PubMed ID: 29195768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal dialysis-related peritonitis caused by vancomycin-resistant Enterococcus faecium.
    Unal A; Agkus C; Kocyigit I; Oymak O; Utas C
    Ther Apher Dial; 2011 Feb; 15(1):115-6. PubMed ID: 21272263
    [No Abstract]   [Full Text] [Related]  

  • 12. Intraperitoneal daptomycin used to successfully treat vancomycin-resistant enterococcus peritonitis.
    Hassoun AA; Coomer RW; Mendez-Vigo L
    Perit Dial Int; 2009; 29(6):671-3. PubMed ID: 19910570
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of CAPD-peritonitis due to glycopeptide-resistant Enterococcus faecium with quinupristin/dalfopristin.
    Lynn WA; Clutterbuck E; Want S; Markides V; Lacey S; Rogers TR; Cohen J
    Lancet; 1994 Oct; 344(8928):1025-6. PubMed ID: 7934410
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectiveness of low-dose daptomycin in the treatment of vancomycin-resistant enterococcal urinary tract infections.
    Fisher L; North D
    Int J Antimicrob Agents; 2009 May; 33(5):493-4. PubMed ID: 19153034
    [No Abstract]   [Full Text] [Related]  

  • 15. [Spontaneous bacterial peritonitis produced by Enterococcus faecium].
    Ferrero OL; Sánchez LA; Escalada C; Martínez-Odriozola P; Miguel F
    Enferm Infecc Microbiol Clin; 2000 Apr; 18(4):201. PubMed ID: 10932406
    [No Abstract]   [Full Text] [Related]  

  • 16. Evolution of high-level daptomycin resistance in Enterococcus faecium during daptomycin therapy is associated with limited mutations in the bacterial genome.
    Kelesidis T; Tewhey R; Humphries RM
    J Antimicrob Chemother; 2013 Aug; 68(8):1926-8. PubMed ID: 23580562
    [No Abstract]   [Full Text] [Related]  

  • 17. Failure of high-dose daptomycin for bacteremia caused by daptomycin-susceptible Enterococcus faecium harboring LiaSR substitutions.
    Munita JM; Mishra NN; Alvarez D; Tran TT; Diaz L; Panesso D; Reyes J; Murray BE; Adachi JA; Bayer AS; Arias CA
    Clin Infect Dis; 2014 Nov; 59(9):1277-80. PubMed ID: 25107294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimum inhibitory concentration versus minimum biofilm eliminating concentration in evaluation of antibiotic sensitivity of enterococci causing peritonitis.
    Sepandj F; Ceri H; Gibb A; Read R; Olson M
    Perit Dial Int; 2007; 27(4):464-5. PubMed ID: 17602158
    [No Abstract]   [Full Text] [Related]  

  • 19. [Infection caused by glycopeptide resistant pathogens].
    Korn SJ; Stille W
    Internist (Berl); 2000 Dec; 41(12):1344-52. PubMed ID: 11189069
    [No Abstract]   [Full Text] [Related]  

  • 20. Peritoneal dialysis fluid concentrations of linezolid in the treatment of vancomycin-resistant Enterococcus faecium peritonitis.
    DePestel DD; Peloquin CA; Carver PL
    Pharmacotherapy; 2003 Oct; 23(10):1322-6. PubMed ID: 14594349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.